Manchester Science Partnerships (MSP) and Bruntwood have revealed plans for the first phase of development at their flagship 162-hectare life science campus at Alderley Park, Cheshire. The plans centered on the Mereside science campus and were revealed at MIPIM – the annual international property conference held in Cannes, France.
The session, titled ‘Translating Science into Place’, highlighted Manchester’s role in driving innovation and growth for the UK and celebrated Manchester’s future host city status as ‘European City of Science 2016’. The role of the Universities and the growing science and technology sectors was covered in speeches by Professor Dame Nancy Rothwell, Chris Oglesby MSP Chairman and CEO Bruntwood, and Rowena Burns CEO Manchester Science Partnerships.
The plans signal the first major step for MSP’s vision to transform Alderley Park, AstraZeneca’s former headquarter, into a thriving open innovation community for life science businesses, with over 7,000 high-value jobs planned on-site in the next decade. Bruntwood and MSP have committed to €42.1M capital investment for the next three years at Alderley Park to deliver 1.5m sq ft lettable lab and workspace,